|
⚲
|
| Keyboard |
| Todd Brady | |
|---|---|
| Firm | |
| Address | 910 Hilliard Rome Road East Columbus, OH 43228 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Hyperframe Inc | 021-573938 | Director | 18.3 M of 18.3 M |
||
| Hyperframe Inc | 021-440363 | Executive Officer | 9.7 M | ||
| VERO Biotech Inc | 021-426342 | Director | 27.3 M of 99.5 M |
||
| Avidity Biosciences Inc | 021-353299 | Director | 100.5 M of 103.8 M |
||
| Aldeyra Therapeutics Inc | 021-332606 | Executive Officer | 10.0 M of 25.0 M |
||
| GENO LLC | 021-295706 | Director | 29.9 M of 35.1 M |
||
| Oncobiologics Inc | 021-295363 | Director | 3.3 M of 40.1 M |
||
| RX Green Solutions LLC | 021-291448 | Executive Officer | 5.3 M of 10.0 M |
||
| Avidity Biosciences LLC | 021-277805 | Director | 18.0 M of 23.3 M |
||
| Therabron Therapeutics Inc | 021-277047 | Director | 2.3 M of 6.0 M |
||
| Tyrogenex Inc | 021-258194 | Director | 0.5 M of 12.0 M |
||
| Oncobiologics Inc | 021-253745 | Director | 6.3 M of 50.0 M |
||
| Oncobiologics Inc | 021-249236 | Director | 14.5 M of 14.5 M |
||
| Oncobiologics Inc | 021-245409 | Director | 31.1 M of 31.1 M |
||
| Aldeyra Therapeutics Inc | 021-233587 | Executive Officer | 2.0 M of 4.0 M |
||
| Aldeyra Therapeutics Inc | 021-233108 | Executive Officer | 7.8 M of 18.4 M |
||
| Sebacia Inc | 021-219021 | Director | 11.0 M of 16.0 M |
||
| Novadigm Therapeutics Inc | 021-203930 | Director | 7.0 M of 25.0 M |
||
| RX Green Solutions LLC | 021-201933 | Executive Officer | 0.4 M of 0.5 M |
||
| Sebacia Inc | 021-199015 | Director | 6.5 M of 13.5 M |
||
| Cantex Pharmaceuticals Inc | 021-192030 | Director | 3.3 M of 3.3 M |
||
| Aldexa Therapeutics Inc | 021-189330 | Executive Officer | 4.8 M of 8.8 M |
||
| Sebacia Inc | 021-176483 | Director | 6.5 M of 11.5 M |
||
| Sebacia Inc | 021-160592 | Director | 5.6 M of 5.6 M |
||
| Asmacure Inc | 021-159991 | Director | 4.0 M of 4.0 M |
||
| Paringenix Inc | 021-145926 | Director | 4.4 M of 5.0 M |
||
| Evoke Pharma Inc | 021-144215 | Director | 6.0 M of 6.0 M |
||
| Asmacure Inc | 021-138695 | Director | 3.9 M of 3.9 M |
||
| Novadigm Therapeutics Inc | 021-119975 | Director | 20.6 M | ||